A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors-Reference-Cited by-同舟云学术

A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors

Published:2019-04-23 Issue:1 Volume:10 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Jumani Rajiv S.,Hasan Muhammad M.,Stebbins Erin E.,Donnelly Liam,Miller Peter,Klopfer Connor,Bessoff Kovi,Teixeira Jose E.,Love Melissa S.,McNamara Case W.,Huston Christopher D.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-019-09880-w.pdf

Reference51 articles.

1. Disease, G. B. D., Injury, I. & Prevalence, C. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388, 1545–1602 (2016).

2. Kotloff, K. L. et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382, 209–222 (2013).

3. Liu, J. et al. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet 388, 1291–1301 (2016).

4. Checkley, W. et al. A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium. Lancet Infect. Dis. 15, 85–94 (2015).

5. Shirley, D. A., Moonah, S. N. & Kotloff, K. L. Burden of disease from cryptosporidiosis. Curr. Op. Infect. Dis. 25, 555–563 (2012).

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging therapeutic avenues against Cryptosporidium: A comprehensive review;Veterinary Parasitology;2024-10

2. Treating cryptosporidiosis: A review on drug discovery strategies;International Journal for Parasitology: Drugs and Drug Resistance;2024-08

3. Transcriptional control of the Cryptosporidium life cycle;Nature;2024-05-29

4. Cryptosporidium life cycle small molecule probing implicates translational repression and an Apetala 2 transcription factor in macrogamont differentiation;PLOS Pathogens;2024-04-26

5. Molecular Targets of the 5-Amido-Carboxamide Bumped Kinase Inhibitor BKI-1748 in Cryptosporidium parvum and HCT-8 Host Cells;International Journal of Molecular Sciences;2024-02-26